Unimed Pharma Competitors and Similar CompaniesClear all

Unimed Pharma's competitors and similar companies include Cosmo Pharmaceuticals, Kaleo, Nippon Chemiphar and IBCC.

	Unimed Pharma Unimed Pharma is a company that focuses on the development and production of generic ophthalmologic products.	Cosmo Pharmaceuticals Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy.	Kaleo Kaléo is a company that specializes in human factors engineering and drug-device combination product development.	Nippon Chemiphar Nippon Chemiphar is a pharmaceutical company that specializes in the development of generic drugs.	IBCC IBCC is a pharmaceutical company that manufactures medicinal products, medical devices and food supplements, and consulting.
Founding Date	Founding Date 1994	Founding Date 1997	Founding Date 2005	Founding Date 1950	Founding Date 1991
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech drug development medical devices pharma supplements	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech healthtech medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare drug development medical devices pharma supplements
Locations	Locations Bratislava, SK HQ Sofia, BG Zagreb, HR Tallinn, EE Rīga, LV Vilnius, LT București, RO see more	Locations Dublin, IE HQ	Locations Richmond, US HQ	Locations Chiyoda City, JP HQ Fukuoka, JP Osaka, JP Saitama, JP Sapporo, JP Sendai, JP	Locations Rijeka, HR HQ Zürich, CH
Employees	Employees N/A	Employees 321	Employees 1222% decrease	Employees 887	Employees 11
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €104.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ¥32.6b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €40.4m (FY, 2025)	Cost of goods N/A	Cost of goods ¥22.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €70.9m (FY, 2025)	Gross profit N/A	Gross profit ¥10.1b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income (€3.5m) (FY, 2025)	Net income N/A	Net income ¥294m (FY, 2025)	Net income N/A